At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Jun 15, 2026 at 07:05 ET
Lifecore Biomedical announced a new commercial manufacturing agreement with an unnamed global pharmaceutical company for an injectable neurology product. This marks the seventh late-stage program win in seven months, signaling strong business development momentum for the CDMO.
- New agreement with a global pharma company for tech transfer and commercial manufacturing of an injectable suspension product for neurological disorders
- Seventh late-stage program win in the last seven months
- Product is a higher-viscosity suspension formulation requiring specialized manufacturing expertise
- Contract is with an undisclosed global pharmaceutical company (counterparty name not disclosed)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access